To measure the mitochondrial activity in CD44+CD36+ tumour cells, we first sorted cancer cells for high (H) or low (L) expression of CD44 and CD36 (Fig. 5a,b), and then quantified the MMP in the different subpopulations. The gene discussed is CD36; the disease is cancer.